代谢与减重手术后的产科、新生儿及儿童结局的风险获益平衡
结果显示术后小于胎龄儿率增加4.4%、大于胎龄儿率降低12.6%,妊娠高血压和妊娠糖尿病等风险降低,但与毛细支气管炎相关的呼吸衰竭风险升高。
要点
- 减重术后小于胎龄儿率增加4.4%,大于胎龄儿率降低12.6%。
- 术后妊娠高血压和妊娠糖尿病的风险显著降低。
- 术后子代毛细支气管炎相关呼吸衰竭风险升高(OR 2.42)。
核心结论
- 代谢与减重手术对妊娠和新生儿的风险获益平衡总体有利,但可能增加与毛细支气管炎相关的呼吸衰竭风险。
主要发现
- 术后小于胎龄儿率增加4.4%,大于胎龄儿率降低12.6%。
- 术后妊娠高血压风险降低(OR 0.16;95%CI 0.10-0.23),妊娠糖尿病风险降低(OR 0.39;95%CI 0.34-0.45)。
- 术后子代骨骼产伤(OR 0.27;95%CI 0.11-0.60)、热性惊厥(OR 0.39;95%CI 0.21-0.67)、病毒性肠道感染(OR 0.56;95%CI 0.43-0.71)及碳水化合物代谢紊乱(OR 0.54;95%CI 0.46-0.63)风险降低。
- 术后子代与毛细支气管炎相关的呼吸衰竭风险升高(OR 2.42;95%CI 1.76-3.36)。
临床怎么用
- 对育龄期减重手术女性应加强术后妊娠管理,关注小于胎龄儿及子代呼吸道感染风险。
局限性
- 需进一步研究以更好评估代谢与减重手术的中长期获益与风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Metabolic and bariatric surgery (MBS) is the most efficient therapeutic option for severe obesity. Most patients who undergo MBS are women of childbearing age. Data in the scientific literature are generally of a low quality due to a lack of well-controlled prospective trials regarding obstetric, neonatal, and child outcomes. OBJECTIVE: To assess the risk-benefit balance associated with MBS around obstetric, neonatal, and child outcomes. DESIGN, SETTING, AND PARTICIPANTS: The study included 53 813 women on the French nationwide database who underwent an MBS procedure and delivered a child between January 2012 and December 2018. Each women was their own control by comparing pregnancies before and after MBS. EXPOSURES: The women included were exposed to either gastric bypass or sleeve gastrectomy. MAIN OUTCOMES AND MEASURES: The study team first compared prematurity and birth weights in neonates born before and after maternal MBS with each other. Then they compared the frequencies of all pregnancy and child diagnoses in the first 2 years of life before and after maternal MBS with each other. RESULTS: A total of 53 813 women (median [IQR] age at surgery, 30 [26-35] years) were included, among 3686 women who had 1 pregnancy both before and after MBS. The study team found a significant increase in the small-for-gestational-age neonate rate after MBS (+4.4%) and a significant decrease in the large-for-gestational-age neonate rate (-12.6%). The study team highlighted that compared with pre-MBS births, after MBS births had fewer occurrences of gestational hypertension (odds ratio [OR], 0.16; 95% CI, 0.10-0.23) and gestational diabetes for the mother (OR, 0.39; 95% CI, 0.34-0.45), as well as fewer birth injuries to the skeleton (OR, 0.27; 95% CI, 0.11-0.60), febrile convulsions (OR, 0.39; 95% CI, 0.21-0.67), viral intestinal infections (OR, 0.56; 95% CI, 0.43-0.71), or carbohydrate metabolism disorders in newborns (OR, 0.54; 95% CI 0.46-0.63), but an elevated respiratory failure rate (OR, 2.42; 95% CI, 1.76-3.36) associated with bronchiolitis. CONCLUSIONS AND RELEVANCE: The risk-benefit balance associated with MBS is highly favorable for pregnancies and newborns but may cause an increased risk of respiratory failure associated with bronchiolitis. Further studies are needed to better assess the middle- and long-term benefits and risks associated with MBS.
引用
- Rives-Lange C, Poghosyan T, Phan A, et al. Risk-Benefit Balance Associated With Obstetric, Neonatal, and Child Outcomes After Metabolic and Bariatric Surgery. JAMA Surg. 2023. PMID: 36350637. doi:10.1001/jamasurg.2022.5450
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。